Press release - 21/11/2025 DFG approves two Collaborative Research Centres In the current selection round, the German Research Foundation (DFG) has granted funding for two new Collaborative Research Centres at the University of Konstanz. Over the next four years, the research teams will be working intensively on trigger signals in biological cells as well as on "silence" and "noise" in human speech.https://www.gesundheitsindustrie-bw.de/en/article/press-release/dfg-approves-two-collaborative-research-centres
Press release - 18/11/2025 Careers in conversation: connecting academia and industry Sixteen leading life science and IT companies, all-new livestreamed presentations, and an informative career panel made for a successful EMBL Industry Day in its second yearhttps://www.gesundheitsindustrie-bw.de/en/article/press-release/careers-conversation-connecting-academia-and-industry
Press release - 17/11/2025 How painkillers can contribute to anemia in cancer patients Researchers from the German Cancer Research Center and the University of Freiburg show how certain painkillers influence the iron metabolism of liver cancer cells and can thus contribute to iron deficiency and anemia in cancer patients.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-painkillers-can-contribute-anemia-cancer-patients
Press release - 13/11/2025 Agile, lightweight, efficient, intelligent: Researchers are developing next-generation robots At the new Institute for Adaptive Mechanical Systems (IAMS) at the University of Stuttgart, the focus is on a new generation of walking robots and “soft robotics”. The researchers are developing adaptable robots inspired by natural movement patterns and made from innovative soft materials. The applications range from healthcare and industrial production to energy supply. https://www.gesundheitsindustrie-bw.de/en/article/press-release/agile-lightweight-efficient-intelligent-researchers-are-developing-next-generation-robots
Press release - 13/11/2025 Software optimizes simulations of the brain A new software enables brain simulations which both imitate the processes in the brain in detail and can solve challenging cognitive tasks. The program was developed by a research team at the Cluster of Excellence ‘Machine Learning: New Perspectives for Science’ at the University of Tübingen. The software thus forms the basis for a new generation of brain simulations which allow deeper insights into the functioning and performance of the brain.https://www.gesundheitsindustrie-bw.de/en/article/press-release/software-optimizes-simulations-brain
Press release - 13/11/2025 New Initiative: Light for Public Health Light affects how we sleep, feel, and perform – yet public awareness of its impact remains limited. The Light for Public Health initiative aims to make evidence-based knowledge on light and health both accessible and actionable, thus turning scientific insight into public benefit.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-initiative-light-public-health
Press release - 07/11/2025 How the biological clock ticks in the female reproductive tract - Breakthrough of the Year Award 2025 for Ângela Gonçalves Endometriosis, menopause, ovarian cancer – still poorly researched and often misdiagnosed. Ângela Gonçalves combines AI, molecular biology, and clinical findings to develop non-invasive tools for early detection, personalized care, and healthier aging. The scientist from the DKFZ-Hector Cancer Institute is the winner of the Falling Walls Foundation's “Breakthrough of the Year 2025” award in the Women's Impact category.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-biological-clock-ticks-female-reproductive-tract-breakthrough-year-award-2025-angela-goncalves
Press release - 07/11/2025 Overcoming Tumor Resistance to Immunotherapy: The European Research Council awards international project led by Heidelberg Medical Faculty In the PRECISION-ImmunoRad project, a multidisciplinary team of scientists from Heidelberg, USA, and Cyprus will unite their expertise to develop novel curative therapeutic strategies for currently hard-to-treat cancers. These strategies will integrate high-precision ion beam therapy with genetically engineered immune cells therapies (CAR-T cells), personalized cancer vaccines, and the targeted reprogramming of the tumor immune microenvironment. https://www.gesundheitsindustrie-bw.de/en/article/press-release/overcoming-tumor-resistance-immunotherapy-european-research-council-awards-international-project-led-heidelberg-medical-faculty
Press release - 05/11/2025 LICIT Solution raises Series A to accelerate sustainable antimicrobial innovation LICIT Solutions completes Series A financing to accelerate the development and commercialization of next-generation sustainable active ingredients for hygiene, preservation, and protective applications LICIT Solutions GmbH, a spin-out from the Institute for Clinical Anatomy and Cell Analysis at the University of Tübingen, has successfully completed its Series A financing round. https://www.gesundheitsindustrie-bw.de/en/article/press-release/licit-solution-raises-series-accelerate-sustainable-antimicrobial-innovation
Press release - 04/11/2025 Brain Tumor Charity supports immunotherapy for childhood brain tumors with 1.5 million pounds sterling Ependymomas, brain tumors that occur particularly in young children, are especially difficult to treat and more than half of the children affected have an increased risk of relapse. As part of an international consortium, the KiTZ, the DKFZ, the MFHD and UKHD have received a grant of 1.5 million pounds sterling (GBP) from the British organization The Brain Tumor Charity to develop a new type of immunotherapy for ependymoma.https://www.gesundheitsindustrie-bw.de/en/article/press-release/brain-tumor-charity-supports-immunotherapy-childhood-brain-tumors-15-million-pounds-sterling
Press release - 29/10/2025 Replacing, reducing and refining animal testing Official launch of integrative 3R Centre at Ulm University Developing replacement methods for animal testing is the main goal of the 3R network. One of three new 3R centres in Baden-Württemberg was launched at Ulm University at the beginning of the year and has now officially started work with a kick-off event. The abbreviation 3R stands for "Replace, Reduce, Refine", i.e. replace and reduce animal testing and improve the conditions for unavoidable animal experiments.https://www.gesundheitsindustrie-bw.de/en/article/press-release/replacing-reducing-and-refining-animal-testing-official-launch-integrative-3r-centre-ulm-university
Press release - 24/10/2025 Freiburg coordinates national early warning system on animal influenza viruses Federal government awards 3.5 million euros in funding to the collaborative research project FLU-PREP. Researchers are developing methods to identify the pandemic potential of new viruses at an early stage.https://www.gesundheitsindustrie-bw.de/en/article/press-release/freiburg-coordinates-national-early-warning-system-animal-influenza-viruses
Press release - 23/10/2025 Predicting Avian Flu Outbreaks in Europe Using Machine Learning Heidelberg researchers identify local outbreak indicators and develop new regional modeling approach. The highly pathogenic avian influenza virus infection – commonly known as bird flu – primarily affects birds. Mammals, however, are also increasingly infected. This increases the probability that the virus will cross over to humans.https://www.gesundheitsindustrie-bw.de/en/article/press-release/predicting-avian-flu-outbreaks-europe-using-machine-learning
Help for tracheostomy patients - 23/10/2025 Biomimetic speaking valve: how a carnivorous plant makes speaking safer Nature is the best engineer, so they say, and it's always worth taking a closer look. An interdisciplinary group of researchers did just this and drew inspiration from an aquatic plant to develop a novel speaking valve for tracheostomy patients. At the University Medical Center Freiburg, Dr. Claudius Stahl and his team may have addressed a life-threatening issue that can arise in everyday clinical practice by creating a biomimetic valve with…https://www.gesundheitsindustrie-bw.de/en/article/news/biomimetic-speaking-valve-how-carnivorous-plant-makes-speaking-safer
Press release - 16/10/2025 Sleep as the key to understanding ME/CFS The Federal Ministry of Research, Technology and Space (BMFTR) is supporting the “Sleep-Neuro-Path” research network with around 1.6 million euros. Coordinated by the Central Institute of Mental Health (CIMH) in Mannheim, a team of scientists is investigating the role of sleep-related biomarkers in the development of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). https://www.gesundheitsindustrie-bw.de/en/article/press-release/sleep-key-understanding-mecfs
Press release - 15/10/2025 NGS-based diagnostics for identifying sepsis pathogens wins EARTO Innovation Award A method developed at the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB enables bacterial, viral, fungal, or parasitic pathogens in sepsis patients to be identified much faster than before and with the highest precision. The approach is based on high-throughput sequencing of cell-free DNA circulating in the blood and was honored with the EARTO Innovation Award in the "Impact Delivered" category on October 14,…https://www.gesundheitsindustrie-bw.de/en/article/press-release/ngs-based-diagnostics-identifying-sepsis-pathogens-wins-earto-innovation-award
Press release - 13/10/2025 Miniature 3D-printed objects inside the body Dr. Andrea Toulouse from the Institute of Applied Optics receives €1.8 million in funding from the Carl-Zeiss-Stiftung as part of the CZS Nexus program to establish a new junior research group. She conducts research in the field of micro-optics and fiber-based 3D printing. Her vision is to develop 3D printers that will one day be able to build biological tissue directly inside the body.https://www.gesundheitsindustrie-bw.de/en/article/press-release/miniature-3d-printed-objects-inside-body
Press release - 10/10/2025 New tool offers single-cell study of specific genetic variants EMBL scientists created SDR-seq, a tool for single-cell DNA-RNA-sequencing that studies both DNA and RNA simultaneously, linking coding and non-coding genetic variants to gene expression in the same single cell. https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-tool-offers-single-cell-study-specific-genetic-variants
Press release - 09/10/2025 Another step towards a cure Vitamin A transporter reactivates latent HIV Human immunodeficiency viruses (HIV) are insidious. They can evade the immune defence and antiviral drugs by becoming "latent". In this state, they are largely invisible and unassailable. As long as these dormant viruses persist, there is no cure for HIV/AIDS. However, researchers at Ulm University Hospital have discovered a new way to reactivate latent HI viruses. https://www.gesundheitsindustrie-bw.de/en/article/press-release/another-step-towards-cure-vitamin-transporter-reactivates-latent-hiv
Press release - 06/10/2025 3D imaging points to possible cause of sudden cardiac death An imaging technique developed by Freiburg researchers provides insights into cardiac arrhythmias that can cause sudden cardiac death in animal models. The changes discovered could explain why even seemingly healthy people are sometimes affected.https://www.gesundheitsindustrie-bw.de/en/article/press-release/3d-imaging-points-possible-cause-sudden-cardiac-death
Press release - 29/09/2025 Actin scaffold in cell nucleus explains survival of cancer cells Researchers from the Cluster of Excellence CIBSS have demonstrated that an actin scaffold stabilizes the cell nucleus upon mechanical stress. This protective mechanism helps cancer cells to avoid dying during their migration in the body. In the long term, targeted interventions in this mechanism could help to prevent metastases.https://www.gesundheitsindustrie-bw.de/en/article/press-release/actin-scaffold-cell-nucleus-explains-survival-cancer-cells
Press release - 24/09/2025 No GPS in the head: How the brain flexibly switches between internal maps Since their discovery in 2004, the grid cells in the brain, which are important for our orientation, have been regarded as a kind of “GPS in the head.” However, scientists at the DKFZ and Heidelberg University Hospital have now shown that grid cells work much more flexibly than previously assumed. In experiments with mice, the researchers found that the cells adapt their activity to different reference points depending on the situation. https://www.gesundheitsindustrie-bw.de/en/article/press-release/no-gps-head-how-brain-flexibly-switches-between-internal-maps
Press release - 23/09/2025 Mutation in non-coding DNA worsens leukaemia prognosis Ulm study uncovers previously unknown disease-promoting mechanism Why is blood cancer particularly aggressive in some patients? Researchers at Ulm University Hospital have characterised a mutation in the so-called NOTCH1 gene that significantly influences the prognosis of chronic lymphocytic leukaemia (CLL). Remarkably, this mutation is located in the non-coding region of the gene – an area of DNA long considered less relevant for disease mechanisms.https://www.gesundheitsindustrie-bw.de/en/article/press-release/mutation-non-coding-dna-worsens-leukaemia-prognosis-ulm-study-uncovers-previously-unknown-disease-promoting-mechanism
Press release - 23/09/2025 Institutional Partnership: Heidelberg and Harvard Sign Memorandum of Understanding On the basis of the cooperative relations that have developed over time, Heidelberg University and Harvard University are going to deepen and expand their cooperation. They have signed a Memorandum of Understanding to that effect. As an institutional internationalization project, the state of Baden-Württemberg is providing ten million euros to support this initiative, which is part of the state’s “Global Partnership in Science” activities.https://www.gesundheitsindustrie-bw.de/en/article/press-release/institutional-partnership-heidelberg-and-harvard-sign-memorandum-understanding
Press release - 23/09/2025 Not all ALK fusions act the same: Variants influence treatment success in lung cancer About five percent of lung adenocarcinomas, one of the most common forms of lung cancer, are driven by a faulty fusion of two genes, EML4 and ALK. This fusion results in different variants, and until now, clinicians have treated all patients with these fusions the same way. However, new research led by scientists from the German Cancer Research Center (DKFZ) and Stanford University shows that not all fusion variants behave alike. https://www.gesundheitsindustrie-bw.de/en/article/press-release/not-all-alk-fusions-act-same-variants-influence-treatment-success-lung-cancer
Press release - 22/09/2025 Research into novel microelectrodes: Dr. Maximilian Becker receives NanoMatFutur funding With the FeMEA project – Ferroelectric Microelectrodes for Biomedical Applications – Hahn-Schickard is setting a pioneering course in bioelectronics research. The aim of the project is to develop novel microelectrode arrays in which ferroelectric materials are used as functional interfaces in CMOS chips for the first time. https://www.gesundheitsindustrie-bw.de/en/article/press-release/research-novel-microelectrodes-dr-maximilian-becker-receives-nanomatfutur-funding
Press release - 17/09/2025 Fat cells are the guardians of our health Researchers have discovered part of the answer to why some people with obesity or diabetes develop fatty liver disease while others remain healthier. They showed that fat cells have their own protective mechanism that prevents them from dying prematurely under stress. If this mechanism fails, the fat cells disintegrate. This can lead to tissue damage, inflammation and serious metabolic disorders.https://www.gesundheitsindustrie-bw.de/en/article/press-release/fat-cells-are-guardians-our-health
Press release - 17/09/2025 AI model predicts disease risks decades in advance Scientists from the European Molecular Biology Laboratory (EMBL) and the German Cancer Research Center (DKFZ) have developed an AI model that assesses the long-term individual risk for more than 1,000 diseases. The model, which was trained and tested using anonymized medical data from the UK and Denmark, can predict health events over a period of more than a decade.https://www.gesundheitsindustrie-bw.de/en/article/press-release/ai-model-predicts-disease-risks-decades-advance
Press release - 16/09/2025 New CRISPR method leads to a better understanding of cell functions The 2020 Nobel Prize in Chemistry was awarded for the development of CRISPR/Cas9, a method also known as “gene scissors”, which enables researchers to better understand how human cells function and stay healthy. Researchers at the University of Stuttgart have further developed CRISPR for this purpose. They present their CRISPRgenee method in Cell Reports Methods.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-crispr-method-leads-better-understanding-cell-functions
Press release - 15/09/2025 How HIV enters the genome – Researchers identify previously unknown mechanism Researchers at Heidelberg Uni Hospital have decoded a previously unknown mechanism by which HIV-1 selects its integration targets in the human genome. A research team identified RNA:DNA hybrids as molecular signposts for the virus. These findings reveal a vulnerability in the life cycle of HIV and provide therapeutic approaches for specifically controlling HIV reservoirs in the body. This has been one of the obstacles to curative HIV therapies.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-hiv-enters-genome-researchers-identify-previously-unknown-mechanism
Press release - 12/09/2025 In bad company: Immune cells in the tumor environment determine the success of therapy for childhood brain tumors The cellular environment of a tumor can either support or sabotage recovery. The most comprehensive study to date on the tumor microenvironment in low-grade gliomas, conducted by KiTZ, Jena University Hospital, the DKFZ, and Heidelberg University Hospital, shows what a supportive or obstructive “neighborhood” looks like in childhood brain tumors. The study also provides clues as to how tumor communication might be blocked. https://www.gesundheitsindustrie-bw.de/en/article/press-release/bad-company-immune-cells-tumor-environment-determine-success-therapy-childhood-brain-tumors
Press release - 09/09/2025 Soft materials for smarter robots Soft robots, robot systems made of soft materials, open up new perspectives for medical technology and industry. Jun.-Prof. Dr. Aniket Pal from the University of Stuttgart is conducting research into viscoelastic materials that have the potential to embed intelligent functions in soft robots. He is receiving 1.5 million euros in funding for this research as part of the Emmy Noether Program. The funding period began on September 1, 2025.https://www.gesundheitsindustrie-bw.de/en/article/press-release/soft-materials-smarter-robots
Press release - 09/09/2025 Signals from the brain reveal what color a person is seeing Visual areas of the brain can reveal the colors a person is seeing while watching moving color rings. This was the result of a study by the University of Tübingen. Using MRI scanning they recorded images from the brains of subjects who were observing visual stimuli, and identified signals for red, green and yellow. The pattern of brain activity appeared similar in subjects, meaning that the color they saw could be predicted simply by comparison…https://www.gesundheitsindustrie-bw.de/en/article/press-release/signals-brain-reveal-what-color-person-seeing
Press release - 08/09/2025 New and simple detection method for nanoplastics A joint team from the University of Stuttgart in Germany and the University of Melbourne in Australia has developed a new method for the straightforward analysis of tiny nanoplastic particles in environmental samples. One needs only an ordinary optical microscope and a newly developed test strip—the optical sieve. The research results have now been published in “Nature Photonicshttps://www.gesundheitsindustrie-bw.de/en/article/press-release/new-and-simple-detection-method-nanoplastics
Press release - 05/09/2025 After EMBL: Umlaut.bio and its potential role in drug development Alumnus Bastian Linder discusses the origin of this start-up and how a tRNA mechanism is helping scientists understand the importance and use of various RNA modifications as they pertain to disease.https://www.gesundheitsindustrie-bw.de/en/article/press-release/after-embl-umlautbio-and-its-potential-role-drug-development
Press release - 04/09/2025 Rare bone tumors: Tailor-made mini-proteins switch off tumor drivers Chordomas are rare bone tumors for which there are no effective drugs. A research team from the DKFZ and the NCT Heidelberg has now developed a promising approach: Tailor-made mini-proteins specifically block the driver of tumor development. In the result, slowing the growth of chordoma cells in the laboratory and in a mouse model, while also revealing further molecular vulnerabilities of the tumor that could be addressed with approved drugs.https://www.gesundheitsindustrie-bw.de/en/article/press-release/rare-bone-tumors-tailor-made-mini-proteins-switch-tumor-drivers-1
Press release - 03/09/2025 Nature publication: Mechanical tensions as a driver of evolution When embryos grow, cells and tissue are constantly bumping into each other. This creates mechanical tensions that could endanger their development. A team from University of Hohenheim and the Japanese RIKEN Center have discovered that fly embryos have strategies to deal with this pressure. The different species have developed two different solutions. This ability to control mechanical tension could be a key to why so many body plans have evolved.https://www.gesundheitsindustrie-bw.de/en/article/press-release/nature-publication-mechanical-tensions-driver-evolution
Press release - 03/09/2025 Therapeutic vaccination against HPV-related tumors: Nanoparticles make the difference Researchers from the German Cancer Research Center (DKFZ) have collaborated with the SILVACX project group at Heidelberg University to develop a therapeutic vaccination concept that can mobilize the immune system to target cancer cells. The team showed that virus peptides coupled to silica nanoparticles can elicit effective T-cell responses against HPV-related tumors. https://www.gesundheitsindustrie-bw.de/en/article/press-release/therapeutic-vaccination-against-hpv-related-tumors-nanoparticles-make-difference
Press release - 29/08/2025 Sleeping beauties: the biology behind oocyte dormancy The maturation process of oocytes remains paused for several years. Researchers from Konstanz and Göttingen have now found out which protein ensures this state is maintained over such a long period.https://www.gesundheitsindustrie-bw.de/en/article/press-release/sleeping-beauties-biology-behind-oocyte-dormancy
Press release - 26/08/2025 Key mechanism for Alzheimer's disease discovered A molecular mechanism that contributes to the progression of Alzheimer’s disease has been discovered by a research team of Heidelberg University. The team, using an Alzheimer’s mouse model, demonstrated that a neurotoxic protein-protein complex is responsible for nerve cells in the brain dying off and the resulting cognitive decline. This finding opens up new perspectives for the development of effective treatments.https://www.gesundheitsindustrie-bw.de/en/article/press-release/key-mechanism-alzheimers-disease-discovered
Press release - 21/08/2025 Nanodroplets Could Speed Up the Search for New Medicine Until now, the early phase of drug discovery for the development of new therapeutics has been cost- and time-intensive. Researchers at KIT have developed a platform on which extremely miniaturized nanodroplets with a volume of 200 nanoliters per droplet and containing 300 cells per test can be arranged. This platform enables the researchers to synthesize and test thousands of therapeutic agents on the same chip, saving time and resources. https://www.gesundheitsindustrie-bw.de/en/article/press-release/nanodroplets-could-speed-search-new-medicine
Press release - 21/08/2025 Ultrafast Pace in the Brain: New Insights into Calcium Transport and Signal Processing Researchers at the University of Freiburg, together with partners, have uncovered the mechanism of ultrafast transport by calcium pumps in nerve cells. These pumps, complexes of PMCA2 and neuroplastin proteins, operate at more than 5,000 cycles per second and terminate calcium signals within milliseconds – 100 times faster than previously known. They play a crucial role in rapid information processing in the brain. https://www.gesundheitsindustrie-bw.de/en/article/press-release/ultrafast-pace-brain-new-insights-calcium-transport-and-signal-processing
Press release - 14/08/2025 Freezing brain tumor cells in a dormant state Every brain tumor is made up of cells in successive stages of activation. Researchers have now analyzed the individual structure of these activation pyramids in malignant brain tumors. In doing so, they discovered a signaling protein that slows down the transition from a dormant to an activated state by epigenetically reprogramming the cells. The hope is that this will permanently freeze cancer cells in a dormant state and thus halt tumor growth.https://www.gesundheitsindustrie-bw.de/en/article/press-release/freezing-brain-tumor-cells-dormant-state
Press release - 12/08/2025 Biomarkers for Brain Insulin Resistance Discovered in the Blood If the brain no longer responds properly to insulin (insulin resistance), this can lead to overweight, diabetes, and Alzheimer's disease. Researchers at the DZD in Potsdam and Tübingen have discovered small chemical modifications to genetic material (epigenetic changes*) in the blood that indicate how well the brain responds to insulin. These markers could help to detect insulin resistance in the brain – by means of a simple blood test.https://www.gesundheitsindustrie-bw.de/en/article/press-release/biomarkers-brain-insulin-resistance-discovered-blood
Press release - 11/08/2025 The Cerebral Cortex Ages Less than Thought The human brain ages less than thought and in layers – at least in the area of the cerebral cortex responsible for the sense of touch. Researchers at DZNE, the University of Magdeburg, and the Hertie Institute for Clinical Brain Research at the University of Tübingen come to this conclusion based on brain scans of young and older adults in addition to studies in mice. https://www.gesundheitsindustrie-bw.de/en/article/press-release/cerebral-cortex-ages-less-thought
Press release - 05/08/2025 Playing Dominos: how an artificial protein emerges from fitting together individual components The targeted engineering of artificial proteins with unique properties – that is possible with the assistance of a novel method developed by a research team of Heidelberg University. It centers around a new AI model. This allows for forecasting how two proteins have to be fitted together at the molecular level from individual parts – subunits – in order to engineer a functional, adjustable new protein. https://www.gesundheitsindustrie-bw.de/en/article/press-release/playing-dominos-how-artificial-protein-emerges-fitting-together-individual-components
Press release - 04/08/2025 FOXP1 syndrome: Potential therapeutic approach discovered for rare language development disorder FOXP1 syndrome is a congenital disorder in which the brain development of affected children is severely impaired due to a genetic variant. A research team from the Medical Faculty Heidelberg at Heidelberg University has now demonstrated in mice, that the inhibition of a specific enzyme in the brain can improve abnormal behavior and immune cell dysfunction in the brain. The results have been published in the journal Advanced Science.https://www.gesundheitsindustrie-bw.de/en/article/press-release/foxp1-syndrome-potential-therapeutic-approach-discovered-rare-language-development-disorder
Press release - 01/08/2025 Early Pancreatic Cancer Detection Tumors of the pancreas seldom cause symptoms in their early stages. This means that in many cases, they are not diagnosed until late, when the chances of successful treatment are poor. A new non-invasive diagnostic method designed by Fraunhofer researchers is set to make it possible to detect this aggressive form of cancer early on with high accuracy, significantly improving the prognosis for treatment.https://www.gesundheitsindustrie-bw.de/en/article/press-release/early-pancreatic-cancer-detection
Press release - 01/08/2025 In science we trust? Six takeaways from a Science and Society conference EMBL's latest Science and Society conference brought together researchers, ethicists, communicators, policy professionals, and more to discuss the thorny question of trust in science.https://www.gesundheitsindustrie-bw.de/en/article/press-release/science-we-trust-six-takeaways-science-and-society-conference
Breath test replaces invasive diagnostics - 30/07/2025 Novel smartphone sensor offers innovative breath test to detect Helicobacter infection The stomach bacterium Helicobacter pylori is widespread and, if left undetected, can impact our well-being and also lead to serious health conditions. While effective treatments exist, a reliable diagnosis is essential. To address this, researchers have developed an affordable breath test that uses a mini-sensor to detect the presence of the bacterium. They are currently working on a smartphone-compatible version for self-testing.https://www.gesundheitsindustrie-bw.de/en/article/news/novel-smartphone-sensor-offers-innovative-breath-test-detect-helicobacter-infection